New stroke drug shows promise in major trial
Disease control
Recruiting now
This study tests a new medicine called TS23 for people having a stroke caused by a blood clot. The goal is to see if it can safely improve recovery by preventing bleeding in the brain. About 300 adults with moderate to severe stroke will receive either TS23 or a placebo, and thei…
Phase: PHASE2 • Sponsor: Translational Sciences, Inc. • Aim: Disease control
Last updated May 17, 2026 18:40 UTC